Simayala Lisinopril 5/10/20 5mg/10mg/20mg Tablet.
PDF Leaflet Revision Date: 24 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension, congestive heart failure, and post-myocardial infarction.
Dosage (summary)
Starting dose: 10 mg; Maintenance: 20 mg daily; Max: 40 mg.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy; may cause fetal harm.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- Fluoroquinolones
Contraindications
- Hypersensitivity to lisinopril
- History of angioedema
- Severe renal impairment
- Bilateral renal artery stenosis
Common side effects
- Hypotension
- Cough
- Dizziness
- Angioedema
Counselling Points
- Take at the same time daily
- Monitor blood pressure regularly
- Report any signs of swelling or difficulty breathing
Serious warnings
- Risk of hypotension in volume-depleted patients
- Monitor renal function
- Angioedema risk higher in black patients
Important Disclaimer
The Simayala Lisinopril 5/10/20 5mg/10mg/20mg Tablet. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
